Attacking heart disease with novel molecular tools.
Marks
A R
AR
Mount Sinai Medical Medical Center, New York, NY 10029, USA.
D015906:Angioplasty, Balloon, Coronary; D000818:Animals; D002455:Cell Division / Q000187:drug effects; D002465:Cell Movement / Q000187:drug effects; D003327:Coronary Disease / Q000517:prevention & control / Q000628:therapy*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000494:pharmacology; D008967:Molecular Biology; D015335:Molecular Probes; D011090:Polyenes / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D012008:Recurrence; D016160:Retinoblastoma Protein / Q000187:drug effects; D020123:Sirolimus; D015607:Stents; D014504:Urban Health
D007166:Immunosuppressive Agents; D015335:Molecular Probes; D011090:Polyenes; D016160:Retinoblastoma Protein; D020123:Sirolimus